Assessment of an oral mycobacterium bovis BCG vaccine and an inactivated M. bovis preparation for wild boar in terms of adverse reactions, vaccine strain survival, and uptake by nontarget species

Clinical and Vaccine Immunology

Volumn 21, Issue 1, 2014, Pages 12-20

  Beltrán Beck, Beatriz ^a   Romero, Beatriz ^b   Sevilla, Iker A ^c   Barasona, Jose A ^a   Garrido, Joseba M ^c   González Barrio, David ^a   Díez Delgado, Iratxe ^a   Minguijón, Esmeralda ^c   Casal, Carmen ^b   Vicente, Joaquín ^a   Gortázar, Christian ^a   Aranaz, Alicia ^b  

^a INSTITUTO DE INVESTIGACIÓN EN RECURSOS CINEGÉTICOS IREC CSIC UCLM JCCM   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c NEIKER and a Vaccine producing Commercial Company CZVSL   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

BCG VACCINE;

ANIMAL EXPERIMENT; ARTICLE; AUTOPSY; BIRD; BOVINE TUBERCULOSIS; CONTROLLED STUDY; DIURNAL ANIMAL; FECES ANALYSIS; FEVER; LOSS OF APPETITE; MYCOBACTERIUM BOVIS; NOCTURNAL ANIMAL; NONHUMAN; PRIORITY JOURNAL; SPECIES DIFFERENCE; TUBERCULOSIS CONTROL; URINALYSIS; VACCINATION; VACCINATION REACTION; WILD BOAR;

ADMINISTRATION, ORAL; ANIMALS; BACTERIAL SHEDDING; BCG VACCINE; BIRDS; DRUG-RELATED SIDE EFFECTS AND ADVERSE REACTIONS; FECES; MOUTH; NASAL CAVITY; SUS SCROFA; SWINE; SWINE DISEASES; TUBERCULOSIS; URINE; VACCINES, ATTENUATED; VACCINES, INACTIVATED;

EID: 84892176799     PISSN: 15566811     EISSN: 1556679X     Source Type: Journal    
DOI: 10.1128/CVI.00488-13     Document Type: Article

References (51)

1. Gortázar C, Delahay RJ, McDonald RA, Boadella M, Wilson GJ, Gavier-Widen D, Acevedo P. 2012. The status of tuberculosis in European wild mammals. Mammal Rev. 42: 193-206. http://dx.doi.org/10.1111/j.1365-2907.2011. 00191.x.
2. Nugent G. 2011. Maintenance, spillover and spillback transmission of bovine tuberculosis in multi-host wildlife complexes: a New Zealand case study. Vet. Microbiol. 151: 34-42. http://dx.doi.org/10.1016/j.vetmic.2011.02.023.
3. Palmer MV, Thacker TC, Waters WR, Gortázar C, Corner LAL. 2012. Mycobacterium bovis: a model pathogen at the interface of livestock, wildlife, and humans. Vet. Med. Int. 2012: 236205. http://dx.doi.org/10.1155/2012/236205.
4. Beltrán-Beck B, Ballesteros C, Vicente J, de la Fuente J, Gortázar C 2012. Progress in oral vaccination against tuberculosis in its main wildlife reservoir in Iberia, the Eurasian wild boar. Vet. Med. Int. 2012: 978501. http://dx.doi.org/10.1155/2012/978501.
5. Boadella M, Vicente J, Ruiz-Fons F, de la Fuente J, Gortázar C. 2012. Effects of culling Eurasian wild boar on the prevalence of Mycobacterium bovis and Aujeszky's disease virus. Prev. Vet. Med. 107: 214-221. http://dx.doi.org/10.1016/j.prevetmed.2012.06.001.
6. Chambers MA, Rogers F, Delahay RJ, Lesellier S, Ashford R, Dalley D, Gowtage S, Davé D, Palmer S, Brewer J, Crawshaw T, Clifton-Hadley R, Carter S, Cheeseman C, Hanks C, Murray A, Palphramand K, Pietravalle S, Smith GC, Tomlinson A, Walker NJ, Wilson GJ, Corner LA, Rushton SP, Shirley MD, Gettinby G, McDonald RA, Hewinson RG. 2011. Bacillus Calmette-Guérin vaccination reduces the severity and progression of tuberculosis in badgers. Proc. Biol. Sci. 278: 1913-1920. http://dx.doi.org/10.1098/rspb.2010.1953.
7. Tompkins DM, Ramsey DSL, Cross ML, Aldwell FE, De Lisle GW, Buddle BM. 2009. Oral vaccination reduces the incidence of tuberculosis in free-living brushtail possums. Proc. Biol. Sci. 276: 2987-2995. http://dx.doi.org/10.1098/ rspb.2009.0414.
8. Waters WR, Palmer MV, Buddle BM, Vordermeier HM. 2012. Bovine tuberculosis vaccine research: historical perspectives and recent advances. Vaccine 30: 2611-2622. http://dx.doi.org/10.1016/j.vaccine.2012.02.018.
9. Britton WJ, Palendira U. 2003. Improving vaccines against tuberculosis. Immunol. Cell Biol. 81: 34-45. http://dx.doi.org/10.1046/j.0818-9641.2002.01143. x.
10. Cross ML, Buddle BM, Aldwell FE. 2007. The potential of oral vaccines for disease control in wildlife species. Vet. J. 174: 472-480. http://dx.doi.org/ 10.1016/j.tvjl.2006.10.005.
11. Murphy D, Corner LAL, Gormley E. 2008. Adverse reactions to Mycobacterium bovis bacille Calmette-Guérin (BCG) vaccination against tuberculosis in humans, veterinary animals and wildlife species. Tuberculosis 88: 344-357. http://dx.doi.org/10.1016/j.tube.2007.11.010.
12. Milstien JB, Gibson JJ. 1990. Quality control of BCG vaccine by WHO: a review of factors that may influence vaccine effectiveness and safety. Bull. World Health Organ. 68: 93-108.
13. Liu J, Tran V, Leung AS, Alexander DC, Zhu B. 2009. BCG vaccines: their mechanisms of attenuation and impact on safety and protective efficacy. Hum. Vaccin. 5: 70-78. http://dx.doi.org/10.4161/hv.5.2.7210.
14. Bricks LF. 2004. Percutaneous or intradermal BCG vaccine? J. Pediatr. (Rio J.) 80: 93-98. (In Portuguese.) http://dx.doi.org/10.1590/S0021- 75572004000200004.
15. Lotte A, Wasz-Höckert O, Poisson N, Dumitrescu N, Verron M, Couvet E. 1984. BCG complications: estimates of the risks among vaccinated subjects and statistical analysis of their main characteristics. Adv. Tuberc. Res. 21: 107-193.
16. de Souza GRM, Couto Sant'Anna C, Lapa e Silva J, Biasotto Mano D, Manhães Bethlem N. 1983. Intradermal BCG vaccination complications: analysis of 51 cases. Tubercle 64: 23-27. http://dx.doi.org/10.1016/0041- 3879(83)90046-6.
17. Mukamel E, Layfield LJ, Hawkins RA, Dekernion JB. 1988. The effect of bacillus Calmette-Guerin on the urinary system of pigs. J. Urol. 139: 165-169.
18. Lesellier S, Palmer S, Dalley DJ, Davé D, Johnson L, Hewinson RG, Chambers MA. 2006. The safety and immunogenicity of bacillus Calmette-Guérin (BCG) vaccine in European badgers (Meles meles). Vet. Immunol. Immunopathol. 112: 24-37. http://dx.doi.org/10.1016/j.vetimm.2006.03. 009.
19. Lurie MB. 1934. The fate of BCG and associated changes in the organs of rabbits. J. Exp. Med. 60: 163-178.
20. Palmer MV, Thacker TC, Waters WR. 2009. Vaccination with Mycobacterium bovis BCG strains Danish and Pasteur in white-tailed deer (Odocoileus virginianus) experimentally challenged with Mycobacterium bovis. Zoonoses Public Health 56: 243-251. http://dx.doi.org/10.1111/j.1863-2378.2008.01198.x.
21. Palmer MV, Thacker TC, Waters WR, Robbe-Austerman S, Lebepe-Mazur SM, Harris NB. 2010. Persistence of Mycobacterium bovis bacillus Calmette-Guérin inwhite-tailed deer (Odocoileus virginianus) after oral or parenteral vaccination. Zoonoses Public Health 57:e206-e212. http://dx.doi.org/10.1111/j.1863-2378.2010.01329.x.
22. Schilling C. 1930. Pathologisch-histologische Studien in bezug auf den Calmetteschen Tuberkelbacillus (B.C.G.). Virchows Arch. Pathol. Anat. Physiol. Klin. Med. 278: 462-476.
23. Olsen AW, Brandt L, Agger EM, van Pinxteren LA, Andersen P. 2004. The influence of remaining live BCG organisms in vaccinated mice on the maintenance of immunity to tuberculosis. Scand. J. Immunol. 60: 273-277. http://dx.doi.org/10.1111/j.0300-9475.2004.01471.x.
24. Nol P, Rhyan JC, Robbe-Austerman S, McCollum MP, Rigg TD, Saklou NT, Salman MD. 2013. The potential for transmission of BCG from orally vaccinated white-tailed deer (Odocoileus virginianus) tocattle (Bos taurus) through a contaminated environment: experimental findings. PLoS One 8:e60257. http://dx.doi.org/10.1371/journal.pone.0060257.
25. Corner LAL, Costello E, O'Meara D, Lesellier S, Aldwell FE, Singh M, Hewinson RG, Chambers MA, Gormley E. 2010. Oral vaccination of badgers (Meles meles) with BCG and protective immunity against endobronchial challenge with Mycobacterium bovis. Vaccine 28: 6265-6272. http://dx.doi.org/10.1016/j.vaccine. 2010.06.120.
26. Wedlock DN, Aldwell FE, Keena D, Skinnerc MA, Buddle BM. 2005. Oral vaccination of brushtail possums (Trichosurus vulpecula) with BCG: immune responses, persistence of BCG in lymphoid organs and excretion in faeces. N. Z. Vet. J. 53: 301-306. http://dx.doi.org/10.1080/00480169.2005.36564.
27. Chen J-L, Yu C-C, Chiang J-R, Lee T-C, Yeh M-K, Chiang C-H. 2007. In vitro and in vivo assessments for developing on oral BCG vaccine formulation. J. Food Drug Anal. 15: 213-219.
28. Ballesteros C, Vicente J, Morriss G, Jockney I, Rodríguez O, Gortázar C, de la Fuente J. 2011. Acceptance and palatability for domestic and wildlife hosts of baits designed to deliver a tuberculosis vaccine to wild boar piglets. Prev. Vet. Med. 98: 198-203. http://dx.doi.org/10.1016/j. prevetmed.2010.10.012.
29. Brochier B, Thomas I, Bauduin B, Leveau T, Pastoret PP, Languet B, Chappuis G, Desmettre P, Blancou J, Artois M. 1990. Use of a vaccinia-rabies recombinant virus for the oral vaccination of foxes against rabies. Vaccine 8: 101-104. http://dx.doi.org/10.1016/0264-410X(90)90129-A.
30. Olson CA, Mitchell KD, Werner PA. 2000. Bait ingestion by free-ranging raccoons and nontarget species in an oral rabies vaccine field trial in Florida. J. Wildl. Dis. 36: 734-743. http://dx.doi.org/10.7589/0090-3558-36.4.734.
31. Ballesteros C, Carrasco-García R, Vicente J, Carrasco J, Lasagna A, de la Fuente J, Gortázar C. 2009. Selective piglet feeders improve age-related bait specificity and uptake rate in overabundant Eurasian wild boar populations. Wildl. Res. 36: 203-212. http://dx.doi.org/10.1071/WR08127.
32. Ballesteros C, Vicente J, Carrasco-García R, Mateo R, de la Fuente J, Gortázar C. 2011. Specificity and success of oral-bait delivery to Eurasian wild boarin Mediterranean woodland habitats. Eur. J. Wildl. Res. 57: 749-757. http://dx.doi.org/10.1007/s10344-010-0483-9.
33. Ballesteros C, Garrido JM, Vicente J, Romero B, Galindo RC, Minguijón E, Villar M, Martín-Hernando MP, Sevilla I, Juste R, Aranaz A, de la Fuente J, Gortázar C. 2009. First data on Eurasian wild boar response to oral immunization with BCG and challenge with a Mycobacterium bovis field strain. Vaccine 27: 6662-6668. http://dx.doi.org/10.1016/j.vaccine. 2009.08.095.
34. Garrido JM, Sevilla IA, Beltrán-Beck B, Minguijón E, Ballesteros C, Galindo RC, Boadella M, Lyashchenko KP, Romero B, Geijo MV, Ruiz-Fons F, Aranaz A, Juste RA, Vicente J, de la Fuente J, Gortázar C. 2011. Protection against tuberculosis in Eurasian wild boar vaccinated with heat-inactivated Mycobacterium bovis. PLoS One 6:e24905. http://dx.doi.org/10. 1371/journal.pone.0024905.
35. Ballesteros C, Gortázar C, Canales M, Vicente J, Lasagna A, Gamarra JA, Carrasco-García R, de la Fuente J. 2009. Evaluation of baits for oral vaccination of European wild boar piglets. Res. Vet. Sci. 86: 388-393. http://dx.doi.org/10.1016/j.rvsc.2008.09.003.
36. de la Lastra JMP, Galindo RC, Gortázar C, Ruiz-Fons F, Aranaz A, de la Fuente J. 2009. Expression of immunoregulatory genes in peripheral blood mononuclear cells of European wild boar immunized with BCG. Vet. Microbiol. 134: 334-339. http://dx.doi.org/10.1016/j.vetmic.2008.08.026.
37. Kamerbeek J, Schouls L, Kolk A, Van Agterveld M, Van Soolingen D, Kuijper S, Bunschoten A, Molhuizen H, Shaw R, Goyal M, van Embden J. 1997. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J. Clin. Microbiol. 35: 907-914.
38. Aldwell FE, Keen DL, Parlane NA, Skinner MA, De Lisle GW, Buddle BM. 2003. Oral vaccination with Mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in brushtail possums. Vaccine 22: 70-76. http://dx.doi.org/10.1016/S0264-410X(03)00539-5.
39. Buddle BM, Aldwell FE, Skinner MA, De Lisle GW, Denis M, Vordermeier HM, Hewinson RG, Wedlock DN. 2005. Effect of oral vaccination of cattle with lipid-formulated BCG on immune responses and protection against bovine tuberculosis. Vaccine 23: 3581-3589. http://dx.doi.org/10.1016/j.vaccine.2005. 01.150.
40. Griffin JFT, Mackintosh CG, Slobbe L, Thomson AJ, Buchan GS. 1999. Vaccine protocols to optimise the protective efficacy of BCG. Tuber. Lung Dis. 79: 135-143. http://dx.doi.org/10.1054/tuld.1998.0202.
41. Robinson PA, Corner LAL, Courcier EA, McNair J, Artois M, Menzies FD, Abernethy DA. 2012. BCG vaccination against tuberculosis in European badgers (Meles meles): a review. Comp. Immunol. Microbiol. Infect. Dis. 35: 277-287. http://dx.doi.org/10.1016/j.cimid.2012.01.009.
42. Slobbe L, Lockhart E, O'Donnell MA, Mackintosh C, De Lisle G, Buchan G. 1999. An in vivo comparison of bacillus Calmette-Guerin (BCG) and cytokine-secreting BCG vaccines. Immunology 96: 517-523. http://dx.doi.org/10. 1046/j.1365-2567.1999.00702.x.
43. Aldwell FE, Cross ML, Fitzpatrick CE, Lambeth MR, De Lisle GW, Buddle BM. 2006. Oral delivery of lipid-encapsulated Mycobacterium bovis BCG extends survival of the bacillus in vivo and induces a long-term protective immune response against tuberculosis. Vaccine 24: 2071-2078. http://dx.doi.org/10.1016/ j.vaccine.2005.11.017.
44. Minassian AM, Ronan EO, Poyntz H, Hill AVS, McShane H. 2011. Preclinical development of an in vivo BCG challenge model for testing candidate TB vaccine efficacy. PLoS One 6:e19840. http://dx.doi.org/10.1371/journal.pone.0019840.
45. Elbert B, Gelberg S. 1930. Fresh contributions to the experimental study of BCG. Ann. Inst. Pasteur 45: 59-64.
46. Birkhaug KE. 1933. Protection against tuberculosis with BCG in guinea pigs. Am. Rev. Tuberc. 27: 6.
47. Birkhaug K, McGlynn D, Clark ME. 1952. Viability and dispersion of BCG inoculated subcutaneously in guinea pigs. Exp. Biol. Med. 80: 64-66.
48. Ninni C. 1932. Allure d'infection à bacille de Bang et de l'intoxication diphtérique chez les cobayes traités per le BCG. C. R. Soc. Biol. Paris 109: 705.
49. Griffith AS. 1931. Studies of protection against tuberculosis: results with BCG vaccine in monkeys. His Majesty's Stationery Office, London, England.
50. Cross ML, Henderson RJ, Lambeth MR, Buddle BM, Aldwell FE. 2009. Lipid-formulated BCG as an oral-bait vaccine for tuberculosis: vaccine stability, efficacy, and palatability to brushtail possums (Trichosurus vulpecula) in New Zealand. J. Wildl. Dis. 45: 754-765. http://dx.doi.org/10. 7589/0090-3558-45.3.754.
51. Aldwell FE, Tucker IG, de Lisle GW, Buddle BM. 2003. Oral delivery of Mycobacterium bovis BCG in a lipid formulation induces resistance to pulmonary tuberculosis in mice. Infect. Immun. 71: 101-108. http://dx.doi.org/10.1128/IAI. 71.1.101-108.2003.